Tuttle Capital Management’s Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant EOCW.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-52,741
Closed -$534K 149
2021
Q3
$534K Sell
52,741
-26,736
-34% -$267K 0.62% 57
2021
Q2
$796K Buy
+79,477
New +$796K 0.35% 122

Other funds holding EOCW.U

Tuttle Capital Management's EOCW.U Position: Q4 2021 in Review

Tuttle Capital Management sold out of Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant (EOCW.U) in Q4 2021, closing a stake of 52,741 shares — an estimated $534K sold.

Tuttle Capital Management first reported a position in EOCW.U in Q2 2021 and held it in 2 quarters. The position peaked at $796K in Q2 2021. 41 funds tracked by Wall St. Rank hold EOCW.U as of Q4 2021.

  • Tuttle Capital Management reported no remaining Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant position as of Q4 2021 after selling out during the quarter.
  • Tuttle Capital Management sold 52,741 Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant shares in Q4 2021, an estimated $534K.
  • Tuttle Capital Management first reported a position in Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant in Q2 2021 and held it in 2 quarters.
  • Tuttle Capital Management's Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant position peaked at $796K in Q2 2021.
  • 41 funds tracked by Wall St. Rank held Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant as of Q4 2021.

Based on Tuttle Capital Management's 13F filing for Q4 2021, filed 19 Jan 2022.